EDGAR Filing Documents for 0001104659-18-002227

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001104659-18-002227

Filing Date

2018-01-16

Accepted

2018-01-16 07:31:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	a18-3148_1sc13da.htm	SC 13D/A	45689
	Complete submission text file	0001104659-18-002227.txt		47129

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 18527290
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142

Business Address

Lo Andrew (Filed by) CIK: 0001679076 (see all company filings)

Type: SC 13D/A